The Procter & Gamble Company (PG)
NYSE: PG · Real-Time Price · USD
148.18
+2.47 (1.70%)
At close: Apr 24, 2026, 4:00 PM EDT
148.15
-0.03 (-0.02%)
After-hours: Apr 24, 2026, 7:55 PM EDT
← View all transcripts

Earnings Call: Q2 2023

Jan 19, 2023

Operator

Good morning, and welcome to Procter & Gamble's quarter end conference call. Today's event is being recorded for replay. This discussion will include a number of forward-looking statements. If you will refer to P&G's most recent 10-K, 10-Q, and 8-K reports, you will see a discussion of factors that could cause the company's actual results to differ materially from these projections. As required by Regulation G, Procter & Gamble needs to make you aware that during the discussion, the company will make a number of references to non-GAAP and other financial measures. Procter & Gamble believes these measures provide investors with useful perspective on underlying business trends and has posted on its investor relations website, www.pginvestor.com, a full reconciliation of non-GAAP financial measures. Now I will turn the call over to P&G's Chief Financial Officer, Andre Schulten.

Andre Schulten
CFO, The Procter & Gamble Company

Good morning. Joining me on the call today are Jon Moeller, Chairman of the Board, President and Chief Executive Officer, and John Chevalier, Senior Vice President, Investor Relations. We're going to keep our prepared remarks brief and then turn straight to your questions. Execution of our integrated strategies continued to yield good results in the October to December quarter. Growing organic sales in 9 of 10 categories, holding global aggregate market share, continued productivity savings, improving supplies efficiency, sustained investment in superiority of our brands across all five vectors, product, package, communication, go-to-market, and value, continue to pay benefits for our consumers and retail partners and in turn, for P&G shareholders. Progress against our plan fiscal year to date enables us to increase the guidance range for organic sales growth and maintain ranges for Core EPS growth, free cash flow productivity, and cash return to shareowners.

Moving to the Q2 numbers. Organic sales grew 5%. Pricing added 10 points to sales growth. Mix was up 1 point. Volume declined 6 points, driven by a combination of market contraction, trade inventory reductions, and portfolio reduction in Russia. Growth was broad-based across business units, with each of our 10 product categories growing or holding organic sales. Personal healthcare grew high teens. Feminine care, fabric care, and home care were up high single digits. Hair care was up mid-single digits. Baby care, family care, oral care, and skin and personal care were each up low single digits. Grooming was in line with prior year. Focus markets grew 3% for the quarter, with the U.S. up 6%. Greater China organic sales were down 7% versus prior year as the market continued to be impacted by COVID lockdowns and weaker consumer confidence.

We continue to expect a slow recovery as consumer mobility increases over the coming quarters. Long term, we expect China to return to strong underlying growth rates. Enterprise markets were up 14%, with each of the three regions up 10% or more. Global aggregate market share was in line with prior year, with 27 of our top 50 category country combinations holding or growing share. In the U.S., all outlet value share was in line with prior year, with seven of 10 categories holding or growing share. U.S. volume share is up half a point versus the prior year quarter, delivering sequential improvement from quarter one. Recent innovations like Downy Rinse & Refresh in fabric enhancers and Dawn Powerwash in hand dishwashing are extending superiority advantages and driving value and volume share growth.

Innovation also serves as a catalyst for pricing across our other brands and forms in their category segments. On the bottom line, Core earnings per share were $1.59, down 4% versus prior year. On a currency-neutral basis, Core EPS increased 5%. Core operating margin decreased 170 basis points, primarily due to gross margin pressure from commodities and foreign exchange. Currency-neutral Core operating margin decreased 70 basis points. Productivity improvements were 110 basis point help to the quarter. adjusted free cash flow productivity was 72%, primarily due to a temporary reduction in payables. We returned $4.2 billion of cash to shareowners, approximately $2.2 billion in dividends and $2 billion in share repurchase.

In summary, considering the backdrop of a very challenging cost and operating environment, continued solid results across the top line, bottom line, and cash for the first half of the fiscal year. Moving on to strategy. Our team continues to operate with excellence, executing the integrated strategies that have enabled strong results over the past four years and that are the foundation for balanced growth and value creation. A portfolio of daily use products, many providing cleaning, health, and hygiene benefits in categories where performance plays a significant role in brand choice. Ongoing commitment to and investment in irresistible superiority across the five vectors of product, package, brand communication, retail execution, and value. As discussed during our Investor Day in November, we are renewing our superiority standards to reflect the dynamic nature of this strategy.

Productivity improvement in all areas of our operations to fund investments in superiority, offset cost and currency challenges, expand margins, and deliver strong cash generation. An approach of constructive disruption, a willingness to change, adapt, and create new trends and technologies that will shape our industry for the future, especially important in this volatile environment. An organization that is increasingly more empowered, agile, and accountable with little overlap or redundancy flowing to new demands, seamlessly reporting each other to deliver against our priorities around the world. There are four areas we are driving to improve the execution of the integrated strategies: Supply Chain 3.0, digital acumen, environmental sustainability, and employee value creation. These are not new or separate strategies. They are necessary elements in continuing to build superiority, reduce costs to enable investment and value creation, and to further strengthen our organization.

We expanded on each of these at our Investor Day in November. If you weren't able to attend or listen in remotely, I encourage you to review the materials on our IR events website. Our strategic choices on portfolio superiority, productivity, constructive disruption, and organization are interdependent strategies. They reinforce and build on each other. When executed well, they grow markets, which in turn grows share, sales, and profit. We continue to believe that the best path forward to deliver sustainable top and bottom line growth is to double down on these integrated strategies, starting with commitment to deliver irresistible superior propositions to consumers and retail partners. Moving to guidance. We continue to expect more volatility in costs, currencies, and consumer dynamics as we move through the second half of the fiscal year.

However, we think the strategies we've chosen, the investments we've made, and the focus on executional excellence have positioned us well to manage through this volatility over time. Raw and pack material costs, inclusive of commodities and supplier inflation, are still a significant headwind versus last fiscal year, though we have seen some modest sequential improvement. Based on current spot prices and latest contracts, we now estimate a $2.3 billion after-tax headwind in fiscal 2023. Foreign exchange is also a significant year-over-year headwind, but like raw and pack materials, we've seen modest directional improvement. Based on current exchange rates, we now forecast a $1.2 billion after-tax impact for the fiscal year. Freight costs remain higher versus prior year, and we continue to expect a $200 million after-tax headwind in fiscal 2023.

Combined headwinds from these items are now estimated at approximately $3.7 billion after tax, $1.50 per share, a 26 percentage point headwind to EPS growth for the year. For perspective, recall that we began the year expecting approximately $1.33 of cost and FX headwinds. Despite some modest relief since last quarter, our current outlook is still $0.17 worse than our ingoing position. We are offsetting a portion of these cost headwinds with price increases and productivity savings. We are continuing to invest in irresistible superiority, and we are investing to improve our supply capacity, resilience, and flexibility. As we said before, we believe this is a bottom-line rough patch to grow through with continued investment in the business and underlying strategies.

As I noted at the outset, our solid first half results enable us to raise our organic sales outlook and confirm our guidance ranges on EPS and cash. We are increasing our guidance for organic sales growth from a range of 3%-5% to a range of 4%-5%. Within this company-wide range, there are many puts and takes. As I mentioned, we expect to see some modest improvement in China, European markets have softened as high inflation affects consumer spending. The US remains relatively strong to date, Most enterprise markets remain resilient. On the bottom line, we're maintaining our outlook of core earnings per share growth in the range of in line to +4% versus prior year. The significant headwinds from input costs and foreign exchange keep our current expectations towards the lower end of this range.

This guidance also reflects our intent to remain fully invested to drive our superiority strategy and increase investments as opportunities are available. We continue to forecast adjusted free cash flow productivity of 90%. We expect to pay around $9 billion of dividends and to repurchase $6 billion-$8 billion of common stock. Combined, a plan to return $15 billion-$17 billion of cash to shareowners this fiscal year. This outlook is based on current market growth rate estimates, commodity prices, and foreign exchange rates. Significant additional currency weakness, commodity cost increases, geopolitical disruptions, major production stoppages or store closures are not anticipated within these guidance ranges.

To conclude, we continue to face high year-over-year commodity and transportation costs, inflation in the upstream supply chain and in our own operations, headwinds from foreign exchange, geopolitical issues, COVID disruptions impacting consumer confidence, and historically high inflation impacting consumer budgets. These macroeconomic and market-level consumer challenges we're facing are not unique to P&G, and we won't be immune to the impacts. We attempt to be realistic about these impacts in our guidance and transparent in our commentary. As we've said before, we believe this is a rough patch to grow through, not a reason to reduce investment in the long-term health of the business. We're doubling down on the strategy that has been working well and is delivering strong results. We continue to step forward towards our opportunities, and we remain fully invested in our business.

We are committed to driving productivity improvements to fund growth investments, mitigate input cost challenges, and to deliver balanced top and bottom line growth. With that, we're happy to take your questions.

Operator

Ladies and gentlemen, if you have a question, please press the star key followed by 1 on your phone. If your question has been answered or you would like to withdraw your question, please press the star key followed by 2. Your first question comes from Dara Mohsenian of Morgan Stanley. Please go ahead.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Hey, guys. Good morning.

Andre Schulten
CFO, The Procter & Gamble Company

Morning, Dara.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Just a couple questions on the full year guidance. Obviously, you didn't change the earnings guidance despite FX and commodities each being a little less negative than you originally thought. Is that more sort of making up for some of the sequential moves that we saw in Q1? Is it more you assuming reinvestment in the back half, or is there something else in the back half? Just help us understand the reasoning there. Basically the same question on top line. I don't wanna get into a 10-part question, but there's a bunch of sort of back and forth here. You raised the low end of the full year Organic sales range, but Q2 decelerated a bit versus Q1. The back half in theory implies a deceleration, and volumes were a little weaker in the quarter.

Maybe just taking a step back, you know, how do you feel about the business in terms of looking at retail takeaway in fiscal Q2 and thoughts on the back half of the year? Thanks.

Andre Schulten
CFO, The Procter & Gamble Company

All right. I'll give it a try, Dara. On the total year forecast, I think with half one results in, we are on track, very well on track to deliver the year and the guidance ranges that we're communicating. When you look at our EPS delivery for the balance of the year, we are assuming, as we always do, current spot rates on commodities and foreign exchange. Given our desire to reinvest, we would not assume that every $1 that we see in commodities and foreign exchange immediately flows through to the bottom line. We see significant upside for us to continue to invest in superiority across all five vectors, and if that upside is available to us, we will do that in the short term and the midterm.

We have, also as we said in the prepared remarks, we are still above ingoing assumptions, $0.17 worse than we had at the time when we provided the initial guidance. That leads us to continue to be pointed towards the lower end of the Core EPS range. As you say, with more help, coming, that probably is increasing our confidence to deliver that range, or hopefully slightly better. On the top line, again, when we look at the half one results, we feel very good about our standing here to deliver the higher end of our initial top-line guidance. That's why we raised to 4%-5% Organic sales growth.

The fact that we see low volumes in the current quarter really is important to understand in more depth. The 6% or 5.8% negative volume on the quarter, when you dissect it, about half of that is not really consumption driven. We have a point related to our portfolio choice in Russia, where we cut the portfolio by 50% to focus on essentials versus the full portfolio we were operating before. We have about 2 points related to temporary inventory reductions, which we saw in China with the market heavily impacted by COVID lockdowns in O&D and especially on the offline side of the market, we see retailer inventories reduced to preserve cash.

We saw some inventory reduction in power oral care and appliances in Europe, and we have seen, in late December, very strong consumption in the US, where retail orders haven't quite kept up with that consumption. If you strip that out, the actual consumption-related volume decline is about 3%, on the quarter, which is in line with what we've seen in quarter one, which is in line with our expectation and elasticities that we would have expected given the amount of pricing that is in the market.

What is encouraging to us to raise the top-line guidance is that our volume shares are holding globally, our value shares are holding globally, and when we look at the U.S., our biggest and most important market, we actually see an acceleration of volume share by 50 basis points over the past 3 months and even 80 basis points over the past 1 month. Again, all of that gives us confidence to raise the top-line guidance while we want to preserve the flexibility to continue to invest in superiority to drive more sustainable growth. Honestly, that's got to be our job here over the next few quarters, continue to drive household penetration to reinvigorate overall volume growth in the category.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Hey, Dara, this is John. I would just add a couple pieces of perspective, at a macro level. You know, the world, seems to want, everything to be better, as do I. That's really not reality, though. There's an incredible amount of uncertainty that remains. None of us, I think, globally really understand what the recovery rate in China is gonna be, as an example. nobody really understands, what the new policies and practices are gonna mean in terms of, consumer confidence in that context. You have, the war in Eastern Europe. You have the highest inflation rates in 40 years. You have continued volatility in both the currency markets and the commodity markets. Importantly, that currency exposure for us is not a simple dollar exposure.

There's a lot of cross-rate exposures within that, which I realize makes it difficult to penetrate. For example, the cross rate between the British pound and the euro has a significant impact on our bottom line. All that put together, while... You know, I'm extremely happy with the progress the organization is making. I'm extremely confident that the strategy that we have is the right one and is gonna continue to serve us well. It's just not an easy time to be taking up guidance to the top range of possibility.

Operator

The next question comes from Lauren Lieberman of Barclays. Please go ahead.

Lauren Lieberman
Analyst, Barclays

Great. Thanks. You covered a lot in that answer. I'm gonna switch gears a little bit and maybe talk about capacity investments. I think one of the big drags to gross margin this quarter was those capacity investments. I know there have been some particular areas, like fem care was a big focus. If you could talk a little bit maybe about anything fem care beyond fem care, where you're putting incremental capacity in, to what degree you expect that to remain a drag to profitability over the next couple of quarters, or is it, you know, a multiple year dynamic? 'Cause that would also speak to some pretty healthy expectations around longer term volume trends. I think that's, you know, particularly relevant also as we look a little bit beyond the next quarter or two. Thanks.

Andre Schulten
CFO, The Procter & Gamble Company

Yeah. Hi, Lauren. The short-term effect that we are describing here is indeed fem care related. We see on the top end of the portfolio very strong growth. We have seen very strong growth over the past two years, and we are just need to catch up in terms of overall capacity to demand ratio, both on the top end of our pads business, which is the Radiant or Infinity business. As you well know, we're still not up to full demand levels on Pampers, which we are in the process of installing new capacity in the back half. The investments across businesses to catch up to the very significant increase in terms of business size is underway. We have capacity investments across most businesses.

I wouldn't expect it to be a significant drag on the bottom line. The growth that we anticipate will more than outweigh the cost of investing in capacity, and that's the plan, obviously. We have high confidence in our growth potential, and that's really what's triggering these capacity investments. Just in the U.S., for example, the last quarter was the Q1 we've reached $40 billion in sales, up from $30 billion in sales just four years ago. Again, our growth rate continues to look very positive. Volume shares are up, and better than the market, our volumes are trending to positive numbers year-over-year. We need to keep up with that. The net of it is all positive.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Yeah. Just one quick clarification there. The $40 billion that Andre is referring to is a annualized or a run rate number. It was $10 billion in the quarter, which translates to $40 billion over 4, just so people don't get too carried away.

Andre Schulten
CFO, The Procter & Gamble Company

Carried off.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

The Lauren, the point you made and the point Andre made, there's a lot of upside here as we bring this capacity online. We indicated we're not meeting full demand in some of the feminine protection segments. We have opportunity, as you said, across the board. We're investing pretty significantly. I think as he said, and you've said, the bigger impact will be on our ability to accelerate the top line, which should not be a significant bottom-line drag.

Operator

The next question comes from Bryan Spillane of Bank of America. Please go ahead.

Bryan Spillane
Managing Director, Bank of America

Thanks, operator. Good morning, everybody. I had one clarification and one question. The clarification, I think in response to Dara's question, you cited a 3-point hit to volume from basically, you know, Russia and shipping behind consumption. If we had that back, organic sales would've been closer to an 8% versus a 5%. I just wanna make sure that was the way we should be thinking about it?

Andre Schulten
CFO, The Procter & Gamble Company

That's correct.

Bryan Spillane
Managing Director, Bank of America

Okay. Thank you. As we look into the back half of the year, I guess just if you could comment on two things. One is, has anything changed in terms of your view of the macro setup? You know, just is the operating environment, you know, the same, better, worse than what you were expecting? Also, just would we expect maybe to rebuild some of the inventory, the undershipment that occurred in the Q2 or the first half? Would we get any of that back in the second half?

Andre Schulten
CFO, The Procter & Gamble Company

I would say the operating environment continues to be difficult, and we expect it to be difficult in the second half. While I think the U.S. is holding up very well, enterprise markets are holding up very well, as Jon said earlier, recovery in China will be very hard to predict, and probably not a straight line. We expect China to be difficult in the second half as it was in the first half. The European markets will continue to have to work through very high inflation numbers.

I think we've seen a little bit of help via a warmer winter season that has helped energy prices. Europe is not through, I think inflationary pressures and consumers are still to see many of the consequences in terms of their heating bills, as we are entering February and March. That doesn't change anything we do. I think the best way for us to get through all of this is to continue to invest in the business and to continue to execute with excellence, which the organization is doing and which is driving these good results. Our ability to carefully balance pricing and productivity to offset the inflationary pressures is critical. Within pricing, careful execution and combining pricing with innovation and sufficient investment to drive superiority of our brands is critical.

that's why we want to preserve some level of flexibility, to do those investments as we get through the second half.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Just a little bit of color on the inventory piece, which has been accurately described a couple of times here. This is a fairly simple dynamic that's occurring. When there is supply volatility and uncertainty, it causes retailers to build higher inventory levels. When there's demand volatility, it does the same. We've been through a period where inventories have been a little bit higher than normal in some of our retail channels. Supply assurance is increasing, demand volatility is decreasing, those inventories are understandably being brought down. Bryan, I don't expect that there's a significant swing here quarter- to -quarter. I think this is the system normalizing itself.

Andre Schulten
CFO, The Procter & Gamble Company

I think John is exactly right. Our on-shelf availability is getting better. We're up now to 95% on-shelf availability, up from 93. We make sequential progress. As the supply chain is stabilizing, I wouldn't expect immediate return of those days on hand. I think some of it will come back, but it will take a longer period of time.

Operator

The next question comes from Steve Powers of Deutsche Bank. Please go ahead.

Steve Powers
Managing Director, Deutsche Bank

Yes. Hey, good morning. Thanks. I wanted to go back just to the topic of reinvestment for a minute. It was a big topic last quarter, and I think you convinced us then, and through your commentary to Investor Day that you were actually pretty fully invested in your prior outlook enabled by productivity. As you think about the reinvestment that you're implying incrementally in the new outlook, I'm just... You know, is that should we interpret that as elective and opportunistic for kinda greater medium-term returns? Or is it more, you know, necessary, you know, in the near term, given, you know, more concerning consumer competitive realities? How you'd frame that reinvestment will be helpful. Then if you could, also just you talked about strength in the enterprise markets, resilience.

Just if there are any pockets of particular strength you could call out, that'd be great. Any areas where you're more watchful, that would also be helpful. Thank you.

Andre Schulten
CFO, The Procter & Gamble Company

I would characterize our current media spending and support spending for our brands as sufficient, which we are paying a lot of attention with each of the businesses. Jon pays a lot of attention with each of the businesses to ensure that is the case. Sufficiency is defined as sufficient reach, sufficient frequency. It's not defined as dollars spent. Again, I want to come back to the fact that, yes, we view the current business as fully funded, sufficiently funded in order to continue growing our brands, their top-of-mind awareness, and their equity. When we reinvest, we reinvest because there's a positive return in the short term, and we can further strengthen our brands or specific innovation that is out there.

In the most recent quarter, for example, we've increased quarter-over-quarter our total ad spend by $140 million. That is a function of innovation timing. It's also a function of merchandising support and co-timing advertising with that retailer support. You'll see us adhere to that principle of fully supporting our brands. If there are opportunities to create short-term ROI, we'll continue to double down.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

One other opportunity that we've talked about a little bit this morning. As additional supply comes online, there are often opportunities to increase support for the business to take advantage of that additional capacity. We'll be looking for those, as Andre said, positive ROI opportunities to drive the business. You asked about enterprise markets. You know, when you get down to a country level, of course, it's very variable, but 14% growth on the top line, all three regions growing at over 10%. The strength is pretty broad there.

Andre Schulten
CFO, The Procter & Gamble Company

Yeah. If you look at L.A., 21% growth, for example. That would be the top end of the growth and fairly consistent here. Enterprise markets continue to deliver very strong results. Last point, maybe on the media investment, the synergies we're able to create are, A, real and not insignificant. If you look at baby care, for example, that business has grown 10% last year. They have completely shifted the way they run their media. They've increased reach by 20%, increased top-of-mind awareness by 26%. All of that while they saved 15% of their media spend. The equation here really allows for sufficiency at lower cost.

John Chevalier
SVP, Investor Relations, The Procter & Gamble Company

That, again, just for clarity, is a U.S. dynamic that Andre just described, the 10% growth. I'll leave it there.

Operator

The next question comes from Olivia Tong of Raymond James. Please go ahead.

Olivia Tong
Managing Director, Raymond James

Great. Thank you. If memory serves me right, much of the pricing actions from last year will start to lap in the March quarter. In your view, is the December quarter the one that has the biggest spread between price and volume? You know, could you talk about where your elasticities stand relative to historical view, and if and how price and volume track at the end of the quarter versus the -6 versus +10 average for the quarter? Thank you.

Andre Schulten
CFO, The Procter & Gamble Company

Hey, Olivia. Let me start with elasticities. The overall view has not changed. We continue to see more favorable elasticities than we would have expected on historical data, pretty much everywhere but Europe-focused markets. You can see with 10% pricing flowing through, and when you strip out the non-consumption related volume effect, a 3% reduction in volume, that is a very benign elasticity that we're seeing in aggregate, and allows us to hold volume share and value share as the pricing flows through. We feel good about, again, the strategy doing what we want it to do and the execution being very diligent in each of the markets.

Europe is the one place where elasticities have returned to what we would have expected more on historical data. That is driven by the increased pressure on the consumer. We're also seeing a little bit of price lag here. Private label, for example, is pricing slower in Europe. That increases temporarily the price gap versus private label. Nothing we didn't plan on, that explains part of the part of the higher elasticities. In terms of peak pricing, you're right, many of the large price increases get lapped this fiscal year. That doesn't mean that we're not putting more pricing in the market. For example, we have a number of price increases that go into effect in February. There's two components here.

One, we're lapping price increases were executed last year, but we're also still passing through some of the cost pressures via incremental pricing around the world.

Operator

The next question comes from Chris Carey of Wells Fargo Securities. Please go ahead.

Chris Carey
Senior Equity Analyst, Wells Fargo Securities

Hi, good morning.

Andre Schulten
CFO, The Procter & Gamble Company

Morning, Chris.

Chris Carey
Senior Equity Analyst, Wells Fargo Securities

I just wanted to come back to Steve's question on investment priorities. You know, if I take your fiscal year outlook, you're clearly implying better margins in the back half of the year. If I just walk through, you know, a gross margin bridge of what perhaps makes sense, it does seem to imply you'll need to see, you know, leverage on the SG&A line in the back half of the year to drive margin expansion, potentially notable SG&A leverage despite sales decelerating.

Again, if you could just help me frame, you know, overall SG&A and whether you think you'll be ending the year with appropriate levels of spending or if you expect investment to maybe grow progressively, you know, over the next 12-18 months as, for example, your capacity, you know, continues to improve as Jon just said.

Andre Schulten
CFO, The Procter & Gamble Company

I wouldn't expect a structural shift in SG&A spend. I think what you're seeing in the run rate is about what we expect to need in order to be sufficiently funded. The growth margin and most of the margin expansion will come from growth margin expansion as we ramp up productivity. Pricing continues to flow through, and that builds growth margin period over period. That'll be the bigger contributor. You know, we're not counting on any major reductions in SG&A beyond what productivity allows us to deliver, again, at current sufficiency levels. We're very carefully looking at what can we reinvest actually and still deliver within the range that we wanna deliver.

Operator

The next question comes from Kaumil Gajrawala of Credit Suisse. Please go ahead.

Kaumil Gajrawala
Managing Director, Equity Research, Credit Suisse

Hey, everybody. Good morning. Your commentary, I guess, just now on taking further pricing, it's obviously appropriate given we have a series of costs that are still coming through. Can you maybe just talk a little bit about the response from retailers, and is that changing in any way? Not that long ago, it seemed across all of CPG, it was maybe easier to get some pricing through. I'm just curious if that's changing in any way.

Andre Schulten
CFO, The Procter & Gamble Company

Morning, Kaumil. The environment continues to be constructive. We don't see much change in retailer conversations. It's focused on how do we best play the role that we need to play as category leader in many of the markets by combining pricing with innovation, executing pricing in a way that consumers can appropriately choose from different price points, different value tiers, and how that plays out at retailer shelf, both virtual and physical shelves in the best possible way, so we can help them grow their category, grow foot traffic, et cetera. Those are really the majority of the conversations. I would characterize this quarter or next quarter as any different than the previous quarters, where really it's about how do we do this? When is the best time to execute?

It's not should we or must we take pricing. I think everybody still understands that we are recovering costs after we recover as much as we can with productivity.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

As Andre said, you know, the conversation, much more constructive for all concerned when we focus on improving consumer value holistically defined. That's exactly what Andre was talking about in terms of the combination of innovation and pricing. When that's the conversation, it takes on a very different nature than a more transactional discussion. Don't forget, our retail partners are the owners of the private label brands that we compete against. They're facing many of the same dynamics in terms of their cost inputs that we are. Just to reconfirm what Andre said, it's been a generally constructive discussion. I don't see anything in my interactions with our retail partners that causes an inflection in that discussion in the near term.

Operator

The next question comes from Robert Ottenstein of Evercore ISI. Please go ahead.

Robert Ottenstein
Senior Managing Director and Partner, Evercore ISI

Great. Thank you very much. Just first a quick follow-up, and then my main question. One, in terms of follow-up, is the volume headwind in this quarter from Russia and sort of the one-offs, is that just a quarter issue, or is that gonna linger on to the following quarters? My primary focus is the market share data that you gave us in terms of the U.S., I think was very impressive, particularly given some of the lingering supply issues that are gonna be resolved soon. Can we expect, perhaps accelerating improvement in market share as the year goes and the supply comes on? Maybe give us a little bit more sense of what the drivers were for the encouraging market share momentum in the U.S.? Thank you.

Andre Schulten
CFO, The Procter & Gamble Company

Yeah. Robert, on the volume side, I think the Russia effect will be with us for one more quarter before we annualize. On the inventory side, as we said before, we believe this was a one-time adjustment. I wouldn't expect this to come back immediately. I wouldn't expect a significant further reduction in inventory. When we look at the U.S., for example, where we have good data in terms of retailer days on hand, we believe we are at pre-COVID levels, which is about the level that, you know, we've proven to operate reliably with our retail partners. I would expect that to be a one-timer with potentially some help coming in back over the next few quarters.

The volume share dynamic in the U.S., you know, is driven largely by fabric care coming back into supply. We have talked in the Q4 of last fiscal year and also in the Q1 of this fiscal year that we had some supply constraints on our fabric care business that we had to address. We also reinstated merchandising support in the U.S. We reinstated media support, that is playing out in volume share accelerating on the fabric care business. The other dynamic is family care sequentially improving from a volume share standpoint, where we have seen a very high base when private label was in less supply and didn't have merchandising in the July to December period of last calendar year. That is being annualized.

Those two will continue hopefully to be a tailwind to our share position in the U.S. As Jon said, it's hard to predict and look around the corner here. There are many, many variables that we don't control. Those two businesses explain the strength and hopefully should have more upside going forward.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Just one attempt at changing maybe a little bit some of the semantics, from supply issue to supply opportunity. Our supply organization has done a terrific job. If you look at the last 15 quarters or so, our organic sales, the amount of organic sales, end of period to beginning of period is up 80%, 90%, which is a really good thing. They've done a tremendous job of trying to keep pace with that. As we talked about, there's just additional upside to fully meet and satisfy that demand.

Operator

The next question comes from Peter Grom of UBS. Please go ahead.

Peter Grom
Analyst, UBS

Thanks, operator, and good morning, everyone. Hope you're doing well. I wanted to ask about the change in the commodity outlook, which for the first time in quite some time, the outlook has actually moved lower sequentially. You know, understanding that there's a lot of moving pieces, Can you just help us understand what's driving that? Is it broad-based, or are there particular inputs where you're starting to see inflation moderate more substantially? Thanks.

Andre Schulten
CFO, The Procter & Gamble Company

Morning, Peter. It really varies, period-over-period, month-over-month. We've seen, you know, pulp was holding relatively steady. It's come down a little bit now on different grades. Propylene, polyethylene has come down a little bit, but it's really broad-based and it's changing, month-over-month, week-over-week. In general, what we're seeing is, as you would have known, the supply situation is easing a little bit, and that's obviously helping the market dynamic both on commodities as well as on transportation and warehousing. There's no guarantee that that will continue. We don't know what China reopening will do to the commodity markets. That's a significant variable that nobody really understands at this point, I would argue.

We're watching this closely, and we continue to forecast based on what we know today, which is spot prices. I think the other dynamic we can't forget is that our suppliers are still working through their input cost inflation, their labor inflation, their energy cost inflation. There are two opposing forces here. One is the desire of our suppliers as contracts roll over to pass that through to us, and the other one is input costs easing in the short term. We have to take both into account when we think about our ability to pass through cost helps.

Operator

The next question comes from Andrea Teixeira of JPMorgan. Please go ahead.

Andrea Teixeira
Analyst, JPMorgan

Thank you. Good morning. I have a clarification and a question. Andrea, in your response, about the destocking that should be over in the next quarter, is that also applicable for China? How are you seeing China consumption rebounding as you exit the quarter and obviously with the reopening? If I can squeeze a real question, can you comment on how you're preparing your portfolio in Europe for potential recession as you called out, things may, the bills, the energy bills may be kicking up now as we enter, your Q3 fiscal? Thank you.

Andre Schulten
CFO, The Procter & Gamble Company

Hey, Andrea. The China destocking, I think, will largely depend on the China reopening, and that's very hard to predict. I think if consumer mobility returns to normal levels quickly, that'll be a tailwind for every retailer with real estate on the ground. That's really the major issue that offline retail is facing. If traffic returns to normal levels, that will be a big help and obviously no further destocking required. I'll leave it at that because I have no good way of knowing, nor does anybody else. We expect consumption in China to re-accelerate to mid-single digits. Over what period is hard to predict, but in the mid-term, that's where we see our China market. It continues to be an important investment market for us.

We have a very capable organization on the ground. They are spending their days and nights to get ready for that. Fine-tune our innovation, ensure we have the best possible marketing programs, both digitally and with our retail partners on the ground. I think on the European portfolio, we have prepared, like everywhere else, our portfolio for a recession. It comes back to the basic strategies on the categories we play in. We are in non-discretionary categories to a large degree that people won't deselect easily. They continue to wash their laundry, they continue to wash their hair. That's step number one for recession-proofing our business model. Step number two is investment in irresistible superiority.

When consumers see the benefit our brands can deliver, the value will be clear to them. Our ability to communicate that value clearly is critical. That's why we continue to invest in both the performance as well as the communication. The last part is just accessibility of the portfolio, both in terms of brand tiering, so having premium brands, but also value brands and price points across different channels, be that discounters or other retailers. I think the portfolio proofing has been done, and I think it's showing results in a very difficult environment that we think speak to the strength of the strategy.

Operator

The next question comes from Kevin Grundy of Jefferies. Please go ahead.

Kevin Grundy
Senior Analyst, Jefferies

Hey, thanks. Good morning, everyone. We've covered a lot of ground. I wanna try to connect the dots here on the 8% Organic sales growth if we exclude the items that Andre called out with comments in the press release around market contraction. In the release, you mentioned market contractions in hair care, grooming, fabric care, baby care, family care, across much of the portfolio. But, you know, as Andre talked about, the Organic sales in the quarter was closer to 8%. If we look at the comp, it was actually an acceleration on a 2-year stack basis.

What I really wanna do is, and I know we've covered a lot of ground on this call, just make sure I'm kind of clear on how you're seeing category growth, how you're seeing elasticities and consumer behavior coming out of the quarter. It seems to me that the quarter is actually, you know, on a like-for-like basis, possibly even better than the street had modeled. Setting aside China, you sound pretty constructive on demand dynamics. You sound pretty good on elasticity, sort of relatively unchanged. I just wanna make sure that's the messaging for investors. Thanks for all that.

Andre Schulten
CFO, The Procter & Gamble Company

Yeah. I would characterize, obviously, the Russia element will be with us, and that's real. I think the market growth has been around 5%-6% with a negative volume component and a very positive price component. I would expect that in the mid-term to moderate to 3%-4% overall growth. Still have a negative volume component with offset by strong pricing that we continue to flow through the market. If you look at overall market size, over the past 3 months, that has been the case, and that's where we expect it to be going forward. That's pretty much in line with how we model the balance of the balance of the fiscal year. Our job here is to be ahead of that, and that's why we're investing.

That's why we're continuing to double down on superiority investments everywhere. Jon, I don't know if you have anything to add.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Yeah. It's a repeat, but it's worth repeating. It's a bit of a raindrop on the parade, Kevin, I just wanna highlight so that we don't get ahead of ourselves, how uncertain, for example, China is. Andre said it several times, we don't have visibility. We have, within our own operations, offices, innovation centers, plants. Our current estimate of the infection rate is up to 80%, we're sitting here in the week before Chinese New Year, when all the traveling occurs. At the same time, we have a government and a populace who desperately wants things to get better.

It's just very hard to say, "Hey, you know, we should assume that as we go forward, China comes back like a tiger." Certainly, we all hope that's true. I hope for China that that's true. You just really need to understand how uncertain things are.

Operator

The next question comes from Mark Astrachan of Stifel. Please go ahead.

Mark Astrachan
Managing Director and Senior Equity Research Analyst, Stifel

Yeah, thanks, and morning, everyone. Wanted to move from that raindrop question to a bit more, funny question and just ask about whether the resilience of the US consumer has surprised you all. You know, sort of what's embedded in guidance from here. I know what you said, Andre, about the category, but that was, I think, on a global basis. How do you know, generally think about US trends from here? Within the portfolio, have there been any surprises relative to historical expectations, meaning things that have performed better than you would have expected, and kind of what are you watching from here from a portfolio standpoint, all within the context of the US business?

Andre Schulten
CFO, The Procter & Gamble Company

Morning, Mark Astrachan. I wouldn't expect the U.S. to fundamentally change. If you look back over the past 6 months, private label shares in the U.S. have been, you know, relatively steady. We've seen 20-30 basis points of increase in private label share, which is a metric we're watching closely. If you look at sequential share, absolute shares of private label, it continues to hover around 16% past 3, 6, and even 12 months. There hasn't been a significant shift in consumer behavior in terms of trade-down. I think the way that our pricing was executed with great support in innovation and great support in terms of marketing spend has helped. Our strategy isn't shifting. I don't see the market shifting significantly. All of that with the caveat that who knows what the next 6 months are gonna bring.

You know, if past behavior over the last 6 months, 9 months is any indication, I think the consumer is relatively steady in the U.S., which gives us great confidence. It's our biggest market. We do well, expanding volume share, as I said, and hopefully have a bit more upside here as family care and fabric care continue to gain momentum.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

This continues to be a market, the U.S. market, that is very responsive in a positive way to innovation that improves performance, both for the product and the package. We have many examples. Dawn Powerwash, as an example, introduced at a premium price. The brand has grown at 50% since that introduction. Dawn has driven 90% of category growth in that situation. Dawn Powerwash, again, a premium priced item that was introduced largely during difficult economic times, as a standalone brand would be the third-largest brand in the category. I just use that as an example for the continued positive responsiveness of U.S. consumers to innovation, and we've got a lot of innovation coming.

Operator

The next question comes from Callum Elliott of Bernstein. Please go ahead.

Callum Elliott
Director and Senior Equity Analyst, Bernstein

Great. Thank you very much for the question. I wanted to come back, please, to the brand spend dynamic. Andre, I think the example you gave for baby care is quite powerful. If you can increase reach so meaningfully while simultaneously cutting dollar spend, I guess that's probably driven by digital and better targeting there versus traditional media. My question is, do you think these benefits are sustainable? Over the longer term, are we not likely to see some of these digital ROIs come back down as digital ad pricing goes up and some of your competitors start to catch up with your capabilities there?

Andre Schulten
CFO, The Procter & Gamble Company

I believe, we believe that, you know, we're just at the beginning actually of that productivity curve. It's driven by 2 things. I think US baby care was one of the more aggressive ones, and one of the more obvious ones when you think about the consumer target. It's very narrow, right? You're looking for households with babies in diapering age. You know, going from mass TV, where you have a lot of waste, to hitting that target, which is about 3%-4% of the population, provided the most obvious opportunity to drive synergies here. We've learned also in other businesses, the opposite works. When you think about fabric care, everybody's doing laundry, so it's got a very wide target that you need to reach.

The fabric care team in the U.S. has brought their media planning and buying in-house, developing proprietary algorithms to better place ads during the TV programming, for example. That in and of itself has allowed $65 million of savings in 1 year, while increasing frequency. Both models work, and both models are still not everywhere. We've got 2 examples in the U.S. There are many categories in the U.S. that are still building their own approach to drive these synergies. There's the whole world outside of the U.S., which is still building on the capabilities that we are developing. We see this as a area of continued investment in terms of our own capabilities with a great ability to drive productivity for years to come.

Operator

The next question comes from Chris Pitcher of Redburn. Please go ahead.

Chris Pitcher
Head of Consumer Staples Research, Redburn

Thank you very much. Apologies for carrying on the inventories question, Jon, you mentioned you were looking at a normalization, in the Investor Day, you showed obviously a significant improvement in your supply chain efficiency. Do you think you're in the position over the next 2 years where U.S. retailers could operate at even lower inventories and improving, you know, your relationship with them? Is working capital part of the conversation that you have with them in sort of helping to form group share of shelf? Thank you for the color on the international business. Could you share with how fast your Indian business grew in the period? 'Cause it looks like the Indian consumer there is recovering and whether you're seeing a sustained double-digit recovery there as well. Thank you.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Thanks for the question. I do think that there's significant opportunity for the entire supply system to operate at lower levels of inventory. One of the enablers there, in addition to supply dependability, is increasingly looking at the supply chain across. We historically looked at it as our supply chain and our customer supply chain. As we're beginning to have conversations about, you know, if this was one supply chain, would we do things differently? The answer is almost yes. The opportunities that are resident within that discussion are significant. I do think we will continue to have that conversation and try to make progress in a way that benefits both ourselves and our retail partners and ultimately the consumer with higher on-shelf availability. Go ahead, Andre.

You wanna talk about India?

Andre Schulten
CFO, The Procter & Gamble Company

Yeah, sure. The India business continues to accelerate. We saw Q1 growing 12% organic sales, Q2 13%. India is a good example of those capabilities that we were just talking about, actually rolling out and being very effective. The digital infrastructure the team has been able to create in India is quite impressive, and that's contributing to our ability to drive disproportionate growth there, both from a sales capability standpoint and from a media capability standpoint.

Operator

The next question comes from Jason English of Goldman Sachs. Please go ahead.

Jason English
Managing Director and Senior Equity Analyst, Goldman Sachs

Hey, good morning, folks. Thanks for slotting me in. Congrats on that sales milestone and the market share progression this quarter. I'm gonna cheat and like many, jam a few questions into one. First, what geographies are you taking the majority of the incremental pricing in? Second, you're signaling more reinvestment on the comm as supply improves. What shape do you expect it to take, i.e., product, advertising, promo, et cetera? Lastly, I don't know if I should read much into this, but you've made substantially more references to volume share rather than value share this quarter. Does this reflect a shift in prioritization and focus for you? Thank you.

Andre Schulten
CFO, The Procter & Gamble Company

Thanks, Jason. On the geographies, I would not see any disproportionate tilt towards one or the other. If you look at the cost structure, the implications, they are pretty similar across the different regions. Timing might shift. Category is obviously shifting.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Yeah. There's one exception to that. Agree totally as it relates to pricing related to commodities, there are some markets, of course, where currencies are devaluing-

Andre Schulten
CFO, The Procter & Gamble Company

Right

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

massively. There is where you'd see our highest amount of pricing. Take Argentina, Turkey, the usual suspects.

Andre Schulten
CFO, The Procter & Gamble Company

Correct. If you look at the enterprise market, that's where we generally take a higher pricing in line with overall inflation in the market. To Jon's point, that will continue to be the case. There are other markets where pricing is notoriously more difficult. Think about Japan, think about the G7 in general. That's where you see less pricing impact. That's not different from what we would have seen over the past few quarters. Look, our desire to reinvest is across all vectors of superiority. It is product package innovation, it's in communication, it's in go-to-market execution. All of those are relevant. They differ by region, by category, obviously.

The reason why we're focusing more on volume share is we believe that it is our job and opportunity to continue to drive penetration of our brands. We have huge runway when you think about our ability to continue to drive consumption in even the most developed categories. We wanna focus our team on continue to drive household penetration, continue to create jobs to be done, continue to drive consumption opportunities. A world in which all of the market growth is driven by pricing is obviously not sustainable. Both elements need to come back in balance, and that's why you see us, you know, talk both elements here between value and volume share.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Just for clarity on this point, though, I am not interested in volume share at the expense of value share. Volume share is a way to deliver value share. At least we not be clear, it's both that are important, not a shift in emphasis between one or the other. The other reason that I wanted to make sure that we talked a little bit about volume is that it's a natural concern when we're taking this pricing as to how your volume's holding up and particularly, how is your volume share holding up. We just wanted to be transparent on how we're seeing it, which is very attractive so far.

Operator

The final question comes from Jonathan Feeney of Consumer Edge. Please go ahead.

Jonathan Feeney
Analyst, Consumer Edge

Good morning, and thanks very much. I wanna ask a simple question that's really complicated. When you talk At the time you gave us the initial commodity guidance for the fiscal year 23, rough numbers, U.S.-based spot costs for freight and energy composite for your company was down something like 9% since then. You have lowered the expectation for commodity inflation. Simple question is, can you Like, are your experience costs for this quarter below their peak? Like, I see the year-over-year was 380 basis points of cost push headwind to gross margin versus 510 basis points last quarter. So there's. Can you confirm there's been a sequential step down?

Secondly, could you in what quarter would we expect costs to no longer be a headwind, like be all in the base? Would that be the June quarter, the September quarter, or is that just impossible to say? I know there's a lot to unpack with cross-currency exposure and things that I don't see in U.S.-based spot, but it does seem like your costs are down from their peak. Thank you.

Andre Schulten
CFO, The Procter & Gamble Company

On the second question, I don't know, is this a very simple answer. On the first question, yes, we see sequential progress on the cost side. As I mentioned earlier, it's important to understand the two opposing forces. We don't buy commodities. We buy pack material, we buy super absorbers, we buy films, et cetera. Our suppliers are still in the process of passing through their own inflation. While their input costs via commodity helps is certainly easing, they also haven't fully caught up to their cost structure hits that they have experienced over the past few quarters. We'll continue to work with them to find the right solution here. When exactly that balance is gonna occur, hard to predict.

Jon Moeller
Chairman of the Board, President, and CEO, The Procter & Gamble Company

Yeah, just one additional piece of detail on that. It's not that they're slow. It's that we have contracts that cover, as Andre said earlier, cover a period of time. In many cases, prices are fixed for a period of time, and then it's time to enter into a new contract. That's what's gonna continue to happen for the foreseeable future. Not forever, but that's why it's difficult, Jason, to look at, and I know, I mean, you acknowledge this, to look at U.S. spot prices as the holistic indicator of the direction of things. That's just not what's, that's not sufficient. Okay. I wanna thank you for joining us today, and thank you for your patience in unpacking all of this. Jon's gonna be...

Jon, Andre, the team will be available the rest of the day to continue helping with that. my own unpack, I am very, very proud and thankful for the efforts of our team to grow 5% organically, to do it across all categories, to continue to hold share, you know, the U.S., build volume share, to be able to increase our sales guidance, all against the backdrop of the significant deceleration of the market in China, the situation in Eastern Europe, the, you know, highest inflation rates in 40 years. This team has done an incredible job of executing our integrated strategy to continue momentum through all of that. Similarly on the bottom line, we talked about the impact on the quarter of commodities, foreign exchange, and transportation.

If you look at the last fiscal year, plus our forecast for the current year, you're talking about 50% of profit being eliminated as a result of headwinds in those three areas. We grew earnings per share last year, the team did. We're forecasting to grow earnings per share modestly this year. It speaks to 2 things I think that are very, very important. 1 is the quality of the team, and 2 is the relevance, the continued relevance of the strategy. For what it's worth, that's my unpack. If you wanna call and discuss that further, I'm happy to do so. Thanks for your time.

John Chevalier
SVP, Investor Relations, The Procter & Gamble Company

That concludes today's conference. Thank you for your participation. You may now disconnect. Have a great day.

Powered by